Is Cannabidiol During Neurodevelopment a Promising Therapy for Autism? The question of whether cannabidiol (CBD), a compound derived from the cannabis plant, could serve as an effective therapy for autism spectrum disorder (ASD) during neurodevelopmental stages is gaining significant attention in the scientific community. As detailed in a comprehensive review Read more…
The therapeutic potential of cannabidiol (CBD), a non-psychoactive component of cannabis, has been increasingly recognized in various biomedical fields. CBD has been shown to possess a wide range of properties beneficial for managing and potentially treating different health conditions. A key review documented in the study, “Cannabidiol as an Emergent Read more…
Recent research delves into the pharmacological landscape of GPR18, a G-protein-coupled receptor, and its activation by cannabinoid compounds. This pivotal study, titled “Activation of GPR18 by cannabinoid compounds: a tale of biased agonism”, unveils the complexities of GPR18’s interaction with cannabinoids, revealing a nuanced mode of action termed biased agonism. Read more…